Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance

In recent years, cancer therapies using immune checkpoint inhibitors (ICIs) have achieved meaningful success, with patients with advanced tumors presenting longer survival times and better quality of life. However, several patients still do not exhibit good clinical outcomes for ICI therapy due to l...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Jingjing, Zhou, Mei, Liao, Tingting, Kuang, Wenlong, Xia, Hui, Yin, Zhengrong, Tan, Qi, Li, Yumei, Song, Siwei, Zhou, E, Jin, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988234/
https://www.ncbi.nlm.nih.gov/pubmed/35399527
http://dx.doi.org/10.3389/fcell.2022.818453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988234/
https://www.ncbi.nlm.nih.gov/pubmed/35399527
http://dx.doi.org/10.3389/fcell.2022.818453

Ejemplares similares